KAWASAKI, Japan, Oct. 22, 2025 /PRNewswire/ -- Toshiba Group has announced that its heavy ion therapy system CI-1000 was ...
Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the “Company” or “ZCT”), a FemTech medical device ...
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...
43mon MSN
Elironrasib may overcome resistance to prior KRAS G12C inhibition in non-small cell lung cancer
Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer ...
The New Voice of Ukraine on MSN
Kyiv opens Ukraine’s first Therapeutic Garden
Lighting plays a central role in the garden’s restorative design. Developed by Mykola Kabluka, an artist, lighting designer, ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
ICH gives CGT developers a regulatory framework that finally matches the speed and flexibility their groundbreaking therapies ...
Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...
"I wanted to renovate my whole bathroom one day, but doing this definitely saved me a lot of money," the homeowner says.
Urvi unveiled her new beauty brand ‘skinhut apothecary’ to much excitement and appreciation at the same venue. This brand ...
HealthDay on MSN
When You Start Hormone Therapy In Menopause Matters
Bothersome symptoms of menopause often start years in advance. New research suggests that beginning estrogen therapy during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results